![EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Photo - Image of italian, glaxosmithkline: 128771731 EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Photo - Image of italian, glaxosmithkline: 128771731](https://thumbs.dreamstime.com/z/editorial-gsk-plant-new-anti-hiv-drug-san-polo-di-torrile-italy-october-sunight-enlightening-gsk-logo-plant-128771731.jpg)
EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Photo - Image of italian, glaxosmithkline: 128771731
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64E2/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64E2.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW64TY/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64TY.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo Di Torrile, Italy - October 12, 2018: Luis Arosemena, President And CEO At GSK Italy, Speaks At The Inauguration Of The Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock Photo, San Polo Di Torrile, Italy - October 12, 2018: Luis Arosemena, President And CEO At GSK Italy, Speaks At The Inauguration Of The Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock Photo,](https://previews.123rf.com/images/gonewiththewind/gonewiththewind1810/gonewiththewind181000528/110267966-san-polo-di-torrile-italy-october-12-2018-luis-arosemena-president-and-ceo-at-gsk-italy-speaks-at.jpg)
San Polo Di Torrile, Italy - October 12, 2018: Luis Arosemena, President And CEO At GSK Italy, Speaks At The Inauguration Of The Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock Photo,
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW8WDW/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW8WDW.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW8WE0/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW8WE0.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo Di Torrile, Italy - October 12, 2018: Managers And Workers Of GSK And Italian Authorities Inaugurate The New Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock Photo, Picture and Royalty San Polo Di Torrile, Italy - October 12, 2018: Managers And Workers Of GSK And Italian Authorities Inaugurate The New Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock Photo, Picture and Royalty](https://previews.123rf.com/images/gonewiththewind/gonewiththewind1810/gonewiththewind181000458/109721106-san-polo-di-torrile-italy-october-12-2018-managers-and-workers-of-gsk-and-italian-authorities.jpg)
San Polo Di Torrile, Italy - October 12, 2018: Managers And Workers Of GSK And Italian Authorities Inaugurate The New Plant To Produce Fostemsavir, Innovative Anti-HIV Drug Stock Photo, Picture and Royalty
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW64TM/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64TM.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo Di Torrile, Italy - October 12, 2018: GSK, Italian And VIIV Flags Waving Together On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture San Polo Di Torrile, Italy - October 12, 2018: GSK, Italian And VIIV Flags Waving Together On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture](https://previews.123rf.com/images/gonewiththewind/gonewiththewind1810/gonewiththewind181000490/110218250-san-polo-di-torrile-italy-october-12-2018-gsk-italian-and-viiv-flags-waving-together-on-plant.jpg)
San Polo Di Torrile, Italy - October 12, 2018: GSK, Italian And VIIV Flags Waving Together On Plant For Fostemsavir, Innovative Anti-HIV Drug On The Day Of The Inauguration Stock Photo, Picture
![Gsk, 30 milioni di euro per un nuovo impianto a San Polo di Torrile: produrrà un farmaco sperimentale contro l'HIV Gsk, 30 milioni di euro per un nuovo impianto a San Polo di Torrile: produrrà un farmaco sperimentale contro l'HIV](https://www.parmatoday.it/~media/horizontal-hi/6197579984943/gsk-2.jpg)
Gsk, 30 milioni di euro per un nuovo impianto a San Polo di Torrile: produrrà un farmaco sperimentale contro l'HIV
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64FR/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64FR.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist](https://c8.alamy.com/comp/PW64H0/san-polo-di-torrile-italy-12th-october-2018-gsk-and-viiv-flags-waving-together-in-san-polo-di-torrile-plant-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64H0.jpg)
San Polo di Torrile, Italy. 12th October, 2018. GSK and VIIV flags waving together in San Polo di Torrile plant. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist
![EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Image - Image of president, maria: 128774474 EDITORIAL, GSK Plant for New Anti-HIV Drug Editorial Stock Image - Image of president, maria: 128774474](https://thumbs.dreamstime.com/z/editorial-gsk-plant-new-anti-hiv-drug-san-polo-di-torrile-italy-october-luis-arosemena-president-ceo-gsk-italy-speaks-128774474.jpg)